This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slid 3.7% to $26.89 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the NASDAQ Composite Index falling 0.7% to 21,172.86.
This was the stock's second consecutive day of losses.
Moderna Inc. closed 69.6% below its 52-week high of $88.59, which the company reached on August 21st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.6% to $178.84, Pfizer Inc. rose 0.2% to $25.38, and Gilead Sciences Inc. rose 0.64% to $118.73.
Trading volume totaled 6.9 million, compared to the 50-day average of 8.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.